|
IMVT Immunovant Inc 1764013 |
| Balance Sheet |
|
Current Assets
|
412,541,000 |
|
Assets
|
420,932,000 |
|
Current Liabilities
|
68,315,000 |
|
Liabilities
|
68,315,000 |
|
Equity
|
352,617,000 |
|
Shares Out
|
146,367,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-265,237,000 |
|
Investing Cash Flow
|
-558,000 |
| Market Analysis |
Market Cap
|
4,269,534,152 |
|
Price
|
19.28 |
|
BVPS
|
2.41 |
|
PB
|
7.87 |
|
EPS
|
-1.92 |
|
PS
|
0.32 |
|
FCF
|
-265,795,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMVT documents filed with the SEC.
IMVT Filings
Clear
